Nasdaq:US$14.77 (-0.08) | HKEX:HK$23.20 (-0.30) | AIM:£2.27 (-0.03)
搜索
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2008-02-29

Chi-Med Announces Start of Patient Enrolment in a Global Phase IIb Ulcerative Colitis Clinical Trial of HMPL-004, its Leading Anti-Inflammatory Drug Candidate